Press release
Investigation announced for Investors in shares of Organogenesis Holdings Inc. (NASDAQ: ORGO)
An investigation for investors in Organogenesis Holdings Inc. (NASDAQ: ORGO) shares over potential securities laws violations.
Investors who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Organogenesis Holdings Inc. (NASDAQ: ORGO) concerning whether a series of statements by Organogenesis Holdings Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Canton, MA based Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. Organogenesis Holdings Inc. reported that its annual Total Revenue rose from $260.98 million in 2019 to $338.29 million in 2020, and that its Net Loss of $40.45 million in 2019 turned into a Net Income over $17.94 million in 2020.
On October 12, 2021, Value Investors Club issued a report alleging issues at Organogenesis Holdings, Inc., indicating that the wound care medical company has been improperly billing the federal government for $250 million annually. Organogenesis Holdings Inc. also set the price for its new wound covering, Affinity, “exorbitantly high”, which Medicare reimbursed, while making the product lucrative for doctors to use through large rebates.
Shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) declined from $17.00 per share on September 22, 2021, to $9.57 per share on October 12, 2021.
Those who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) here
News-ID: 2435614 • Views: …
More Releases from Shareholders Foundation
Ardent Health, Inc. (NYSE: ARDT) Investor Alert: Deadline in Lawsuit on March 09 …
A deadline is coming up on March 09, 2026 in the lawsuit filed for certain investors of Ardent Health, Inc. (NYSE: ARDT) over alleged securities laws violations by Ardent Health, Inc.
Investors who purchased shares of Ardent Health, Inc. (NYSE: ARDT) have certain options and there are strict and short deadlines running. Deadline: March 09, 2026. Ardent Health, Inc. (NYSE: ARDT) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Sina Corporation (formerly NASDAQ: SINA) Investor Alert: Investigation of potent …
An investigation on behalf of investors in shares of Sina Corporation (formerly NASDAQ: SINA) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors inSina Corporation (formerly NASDAQ: SINA shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in Sina Corporation (formerly NASDAQ:…
Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) s …
An investor, who purchased shares of Stride, Inc. (NYSE: LRN), filed a lawsuit over alleged violations of Federal Securities Laws by Stride, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Stride, Inc. (NYSE: LRN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 12, 2026. NYSE: LRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
More Releases for Organogenesis
Tissue and Organ Transplantation Market Is Going to Boom |• Organogenesis • …
Worldwide Market Reports has recently released a comprehensive research study titled "Tissue and Organ Transplantation Market Size and Forecast 2026-2033: Breakdown by Manufacturers, Key Regions, Types, and Applications." The report has been developed using a combination of primary and secondary research methodologies, ensuring a detailed and accurate analysis. Drawing insights from both historical data and future projections, the study highlights the expected growth of the Tissue and Organ Transplantation market…
Tissue Engineered Skin Substitutes Market Is Going to Boom |• Organogenesis …
Worldwide Market Reports has recently released a comprehensive research study titled "Tissue Engineered Skin Substitutes Market Size and Forecast 2026-2033: Breakdown by Manufacturers, Key Regions, Types, and Applications." The report has been developed using a combination of primary and secondary research methodologies, ensuring a detailed and accurate analysis. Drawing insights from both historical data and future projections, the study highlights the expected growth of the Tissue Engineered Skin Substitutes market…
Skin Substitutes Market Is Going to Boom |• Acelity • Organogenesis
According to Worldwide Market Reports (WMR) highlights that the "Skin Substitutes Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development trends, technological…
Scaffold Technology Market Is Going to Boom |• Organogenesis • Acelity • M …
According to Worldwide Market Reports (WMR) highlights that the "Scaffold Technology Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development trends, technological…
Amniotic Product Market Massive Growth opportunity Ahead | MiMedx, Smith & Nephe …
Exactitude Consultancy has recently released a comprehensive research report titled "Amniotic Product Market Insights, Extending to 2032." This publication spans over 110+ pages and offers an engaging presentation with visually appealing tables and charts that are self-explanatory.
The extensive Amniotic Product market report conducts market research to assist clients in predicting investment in a growing market, expanding their market share, or achieving success with a new product. Various insights about the…
Wound Care Biologics Market Analysis Report 2021 | Smith & Nephew, Organogenesis
The Latest research study released by CMI "Global Wound Care Biologics Market" with 360+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. This report likewise contemplates the worldwide Wound Care Biologics market…
